Inventor · disambiguated record
Alan F. Wahl
Also filed as: WAHL ALAN · WAHL ALAN F
20 granted patents·17 pending applications·995 citations·filing 1999–2018
97Inventor score
Files withSEATTLE GENETICS INC21LAW CHE-LEUNG7ABBVIE BIOTHERAPEUTICS INC2DORONINA SVETLANA O1GILL DAVINDER SINGH1
Top patents by PatentIndex Score
37 records- 0197US8535678B2Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disordersLAW CHE-LEUNG·Filed 2012·Granted Sep 17, 2013·77 cites·25 claims
- 0297US7491390B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2005·Granted Feb 17, 2009·60 cites·28 claims
- 0397US7090843B1Recombinant anti-CD30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2000·Granted Aug 15, 2006·155 cites·18 claims
- 0496US8337838B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersLAW CHE-LEUNG·Filed 2009·Granted Dec 25, 2012·30 cites·28 claims
- 0596US7666422B2Methods for the treatment of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Feb 23, 2010·30 cites·17 claims
- 0695US8609104B2Treatment of B-cell cancers with anti-CD70 antibody-drug conjugatesLAW CHE-LEUNG·Filed 2012·Granted Dec 17, 2013·27 cites·25 claims
- 0795US7662387B2Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disordersSEATTLE GENETICS·Filed 2004·Granted Feb 16, 2010·142 cites·29 claims
- 0895US7641903B2Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disordersSEATTLE GENETICS INC·Filed 2007·Granted Jan 5, 2010·45 cites·22 claims
- 0995US6843989B1Methods for the treatment and prevention of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2000·Granted Jan 18, 2005·57 cites·78 claims
- 1095US6838261B1Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteinsSEATTLE GENETICS INC·Filed 2000·Granted Jan 4, 2005·61 cites·35 claims
- 1194US9345785B2Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugatesLAW CHE-LEUNG·Filed 2009·Granted May 24, 2016·23 cites·34 claims
- 1294US8512707B2Methods of treating drug-resistant cancersDORONINA SVETLANA O·Filed 2010·Granted Aug 20, 2013·22 cites·20 claims
- 1394US7824683B2Methods for augmenting an immune response using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Nov 2, 2010·18 cites·14 claims
- 1494US7695716B2Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2008·Granted Apr 13, 2010·75 cites·38 claims
- 1593US9051372B2Anti-CD70 antibody and its use for the treatment of cancer and immune disordersLAW CHE-LEUNG·Filed 2008·Granted Jun 9, 2015·24 cites·12 claims
- 1693US8647624B2Treatment of immune disorders with anti-CD70 antibodyLAW CHE-LEUNG·Filed 2008·Granted Feb 11, 2014·21 cites·20 claims
- 1793US6946129B1Recombinant anti-CD40 antibody and uses thereofSEATTLE GENETICS INC·Filed 1999·Granted Sep 20, 2005·70 cites·21 claims
- 1892US10233258B2Bispecific binding proteins that bind CD40 and mesothelinABBVIE BIOTHERAPEUTICS INC·Filed 2018·Granted Mar 19, 2019·16 cites·10 claims
- 1992US7510711B2Methods for the treatment of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2005·Granted Mar 31, 2009·14 cites·8 claims
- 2091US7498032B2Methods for treating immune disorders or cancer with anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2004·Granted Mar 3, 2009·28 cites·24 claims
- 2167US2010183636A1Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disordersSEATTLE GENETICS INC·Filed 2009·Application pending·0 cites
- 2266US2008213289A1Recombinant anti-cd30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2008·Application pending·0 cites
- 2362US2010129362A1Treatment of psoriatic arthritis with anti-cd70 antibodySEATTLE GENETICS INC·Filed 2009·Application pending·0 cites
- 2460US2005008637A1Recombinant cells and transgenic organisms encoding anti-CD40 proteinsSEATTLE GENETICS INC·Filed 2004·Application pending·0 cites
- 2557US2008317747A1Recombinant anti-cd30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2008·Application pending·0 cites
- 2656US2011038856A1Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2007·Application pending·0 cites
- 2754US2007258987A1Recombinant Anti-Cd30 Antibodies and Uses ThereofSEATTLE GENETICS INC·Filed 2004·Application pending·0 cites
- 2849US2004018194A1Recombinant anti-CD30 antibodies and uses thereofFiled 2003·Application pending·0 cites
- 2949US2009304590A1Therapeutic compositions and methodsWYETH CORP·Filed 2008·Application pending·0 cites
- 3047US2012121505A1Therapeutic compositions and methodsGILL DAVINDER SINGH·Filed 2012·Application pending·0 cites
- 3146US2006121476A1Cancer associated antigens, sga-56m and sga-56mv, and uses thereofSEATTLE GENETICS INC·Filed 2003·Application pending·0 cites
- 3246US2017342169A1Bispecific binding proteinsABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3345US2007128593A1Sga-1m, a cancer associated antigen, and uses thereofSEATTLE GENETICS INC·Filed 2003·Application pending·0 cites
- 3444US2005180972A1Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disordersFiled 2003·Application pending·0 cites
- 3544US2012294863A1Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune DisordersLAW CHE-LEUNG·Filed 2012·Application pending·0 cites
- 3644US2010215653A1Methods of treating neoplastic, autoimmune and inflammatory diseasesSEATTLE GENETICS INC·Filed 2010·Application pending·0 cites
- 3743US2005123536A1Treatment of immunological disorders using anti-dc30 antibodiesFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →